Immunome
IMNM
$13.83
Share price
-3.96%
Change (1 day)
143.92%
Change (1 year)
Categories
Immunome (IMNM) - Cash on Hand
Cash on Hand as of December 2023 : $0.14 B
According to Immunome's latest financial reports the company has $0.14 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Immunome - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $20.32 M | -58.72% |
| 2021-12-31 | $49.22 M | 23.8% |
| 2020-12-31 | $39.76 M | 1463.74% |
| 2019-12-31 | $2.54 M | 58.74% |
| 2018-12-31 | $1.6 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 46.45% | 🇺🇸 USA |